ABERDEEN STD GOLD ETF TR's ticker is SGOL and the CUSIP is 00326A104. A total of 218 filers reported holding ABERDEEN STD GOLD ETF TR in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,451,500 | -3.0% | 82,052 | +0.8% | 0.60% | -2.7% |
Q2 2023 | $1,495,722 | +103986.4% | 81,422 | +7.0% | 0.62% | -5.2% |
Q1 2023 | $1,437 | +10.6% | 76,127 | +2.4% | 0.66% | +4.1% |
Q4 2022 | $1,299 | -99.9% | 74,349 | +10.5% | 0.63% | -26.6% |
Q3 2022 | $1,072,000 | -7.8% | 67,310 | +0.3% | 0.86% | +78.0% |
Q2 2022 | $1,163,000 | +17.4% | 67,132 | +25.9% | 0.48% | +25.8% |
Q1 2022 | $991,000 | +13.3% | 53,315 | +7.0% | 0.38% | +0.3% |
Q4 2021 | $875,000 | +1.6% | 49,815 | -2.6% | 0.38% | -3.5% |
Q3 2021 | $861,000 | -0.9% | 51,120 | 0.0% | 0.40% | -5.3% |
Q2 2021 | $869,000 | +10.3% | 51,120 | +6.5% | 0.42% | +16.8% |
Q1 2021 | $788,000 | -28.0% | 48,020 | -19.8% | 0.36% | -28.7% |
Q4 2020 | $1,094,000 | -5.5% | 59,900 | -6.1% | 0.50% | -22.8% |
Q3 2020 | $1,158,000 | +4.0% | 63,802 | -1.7% | 0.65% | -5.8% |
Q2 2020 | $1,113,000 | +19.5% | 64,920 | +1.9% | 0.69% | +14.0% |
Q4 2019 | $931,000 | – | 63,700 | – | 0.60% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hudock, Inc. | 1,147,876 | $18,825,000 | 5.89% |
UBP Investment Advisors SA | 716,194 | $11,750,000 | 4.80% |
swisspartners Ltd. | 305,000 | $5,011,000 | 4.07% |
Darwin Wealth Management, LLC | 1,380,786 | $22,644,000 | 3.95% |
Cypress Capital, LLC | 527,505 | $8,651,000 | 3.53% |
Newman Dignan & Sheerar, Inc. | 430,281 | $7,057,000 | 2.56% |
SimpliFi, Inc. | 318,301 | $5,220,000 | 2.44% |
Allen Capital Group, LLC | 577,017 | $9,463,000 | 2.08% |
Almanack Investment Partners, LLC. | 1,191,188 | $19,536,000 | 1.99% |
American Money Management, LLC | 314,165 | $5,152,000 | 1.92% |